Abstract:AbstractReprogramming the immunosuppressive tumor microenvironment by modulating macrophages holds great promise in tumor immunotherapy. As a class of professional phagocytes and antigen‐presenting cells in the innate immune system, macrophages can not only directly engulf and clear tumor cells, but also play roles in presenting tumor‐specific antigen to initiate adaptive immunity. However, the tumor‐associated macrophages (TAMs) usually display tumor‐supportive M2 phenotype rather than anti‐tumor M1 phenotype. They can support tumor cells to escape immunological surveillance, aggravate tumor progression, and impede tumor‐specific T cell immunity. Although many TAMs‐modulating agents have shown great success in therapy of multiple tumors, they face enormous challenges including poor tumor accumulation and off‐target side effects. An alternative solution is the use of advanced nanostructures, which not only can deliver TAMs‐modulating agents to augment therapeutic efficacy, but also can directly serve as modulators of TAMs. Another important strategy is the exploitation of macrophages and macrophage‐derived components as tumor‐targeting delivery vehicles. Herein, we summarize the recent advances in targeting and engineering macrophages for tumor immunotherapy, including (1) direct and indirect effects of macrophages on the augmentation of immunotherapy and (2) strategies for engineering macrophage‐based drug carriers. The existing perspectives and challenges of macrophage‐based tumor immunotherapies are also highlighted.

Harnessing Tumor-Associated Macrophages As Aids for Cancer Immunotherapy

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy.

Tumor-Associated Macrophages: A Potential Target For Cancer Therapy

Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer

Tumor‐associated Macrophages in Immunotherapy

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Harnessing Anti‐tumor and Tumor‐tropism Functions of Macrophages Via Nanotechnology for Tumor Immunotherapy

Targeting tumor-associated macrophages for cancer treatment

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Therapeutic Potential of Tumor Associated Macrophages

Macrophage-modulating nanomedicine for cancer immunotherapy

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

New insights into the role of macrophages in cancer immunotherapy

Reprogramming Tumor Associated Macrophages Toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy

Tumor associated macrophages (TAMs): from mechanisms to therapeutic implications

Tumor-Associated Macrophages in Tumor Immunity